U.S. :
+1-206-701-6702
UK :
+44-020-8133-4027
JAPAN :
+81-50-5539-1737
INDIA :
+91-848-285-0837
Press Release: Europe Animal Healthcare Market to Surpass US$ 17,837.8 Million by 2027
The complete version of the Report will include the impact of the COVID-19, and anticipated change on the future outlook of the industry, by taking into the account the political, economic, social, and technological parameters.
Animal healthcare focuses on effective animal health management by diagnosing and treating the diseases. Outbreak of animal diseases restrict trading of animal origin products and increases cost of disease management and also hampers the global economy.
The Europe animal healthcare market size is estimated to be valued at US$ 13,119.7 million in 2020 and is expected to exhibit a CAGR of 4.5% over the forecast period (2020-2027).
Figure 1. Europe Animal Healthcare Market Value (US$ Mn), by Country, 2020
Increasing incidence of zoonotic viral pathogens and increasing expansion strategies adopted by manufacturers are factors propelling growth of the Europe animal healthcare market
Increasing product launches and strategic collaborations between manufacturers and regional authorities to address increasing demand for animal healthcare is contributing to the market growth. According to the Animal Disease Notification System (ADNS), 2018, in Bulgaria, around 14 outbreak of A(H5N8) viruses and highly pathogenic avian influenza (HPAI) in poultry was reported from August 2018 to November 2018. To address the increasing prevalence of these zoonotic diseases, regional governments are focused on improving animal health by collaborating with manufacturers to promote research & development of new drug treatments.
Moreover, strategies adopted by manufacturers to expand their product portfolio and market presence is expected to propel growth of the market over the forecast period. For instance, in July 2019, Ceva Santé Animale acquired IDT Biologika GmbH’s veterinary biopharmaceutical portfolio, which is expected to strengthen Ceva’s product offerings.
| Report Coverage | Details | ||
|---|---|---|---|
| Base Year: | 2019 | Market Size in 2020: | US$ 13,119.7 Mn |
| Historical Data for: | 2016 to 2019 | Forecast Period: | 2020 to 2027 |
| Forecast Period 2020 to 2027 CAGR: | 4.5% | 2027 Value Projection: | US$ 17,837.8 Mn |
| Geographies covered: |
|
||
| Segments covered: |
|
||
| Companies covered: |
Merck & Co., Inc., Virbac, Dechra Pharmaceuticals Plc., Vetoquinol S.A., Zoetis Inc., Ceva Santé Animale, Bayer AG, Elanco, Evonik Industries AG, and Archer Daniels Midland Company |
||
| Growth Drivers: |
|
||
| Restraints & Challenges: |
|
||
Moreover, increasing implementation of regulatory guidelines by regional and local authorities in Europe for overall improvement of animal healthcare is expected to drive the market growth over the forecast period. For instance, in 2018, the European Medicine Agency initiated multi-stakeholder workshop for providing guidelines on veterinary regulatory science and offered proposals for development of veterinary medicine.
Figure 2. Europe Animal Healthcare Market Share (%), by Indication, 2020
Increasing in the animal farming is expected to drive the market growth over the forecast period
The significant increase in animal farming in Europe has led to a rise in demand for efficient animal health services in order to improve food safety. According to the U.S. Department of Agricultural (USDA) report published in 2018, Lithuania is the largest poultry meat producer among the Baltic States in Europe, and production of chicken meat in Lithuania was around 110,700 MT in 2015, which was an increase of 11% from 2014.
Increasing number of regulations for animal vaccinations have led to high adoption of animal health products, which is expected to drive the market growth over the forecast period. For instance, the European Commission for the control of foot-and-mouth disease (EuFMD), and the Food and Agriculture Organization developed a progressive control pathway for managing foot-and-mouth disease (FMD).
Europe Animal Healthcare Market Restraints
However, stringent regulations on sales and usage of antibiotics, and high cost of animal healthcare services are expected to hamper growth of the Europe animal healthcare market. For instance, in 2017, the HealthforAnimals Association launched Antibiotics Commitment, a program associated with antimicrobial resistance (AMR), which promotes responsible use of antibiotics. Such awareness programs and stringent regulations have led to a decline in sales of antimicrobial agents used for veterinary treatment. According to the European Medicines Agency (EMA) report published in October 2018, there was 20% decrease in the overall sales of veterinary antimicrobials across Europe between 2011 and 2016.
Europe Animal Healthcare Market – Impact of Coronavirus (Covid-19) Pandemic
COVID-19 has had a significant impact on the livestock sector. The actions taken in many countries across the world to stop the spread of the coronavirus such as travel restrictions, nationwide lockdowns, and border controls have led to the following consequences:
Such factors have led to a decrease in sales and processing capacity of animal products, and a slowdown of the market growth.
Key Players
Major players operating in the Europe animal healthcare market include Merck & Co., Inc., Virbac, Dechra Pharmaceuticals Plc., Vetoquinol S.A., Zoetis Inc., Ceva Santé Animale, Bayer AG, Elanco, Evonik Industries AG, and Archer Daniels Midland Company.
Animal healthcare include veterinary and over-the-counter drugs, supplements, nutraceuticals, vaccines, antibiotics and parasiticides, which are used in the treatment of disease associated with digestive system, immunological system, reproductive system, respiratory, and urinary system of animals. Rapid increase in zoonotic viral diseases and other animal-borne diseases can have adverse effects on farming and other occupation. Efficient animal healthcare can facilitate enhanced productivity of livestock to the farmers, as livestock animals provide major protein source through meat and milk. Increasing public-private collaboration to increase awareness about efficient animal healthcare in Europe is expected to drive growth of the Europe animal healthcare market.
Market Dynamics
Market players are focused on investments in research and development activities in order to strengthen their market presence in Europe, and to develop novel products to prevent diseases in livestock and pets. For instance, in May 2019, Boehringer Ingelheim collaborated with the Veterinary Oncology Advisory Board (VOAB) comprising experts in veterinary oncology from the U.S., Europe, and Japan to develop therapeutic veterinary solutions. Moreover, in 2018, Boehringer Ingelheim invested US$ 220 million for the development of a production center for veterinary public health in French Rhône-Alpes region, also known as the European vaccine valley.
Companies and their subsidiaries operating in Europe region intend to leverage their proprietary technologies for the development of novel therapeutics to treat serious medical conditions in animals. For instance, in April 2019, Interporc, a Spain-based pork board unveiled a new certified animal welfare seal, IAWS, to endorse good practices that will increase demand for animal healthcare, and drive the market growth.
Key features of the study:
Detailed Segmentation:
“*” marked represents similar segmentation in other categories in the respective section.
*Browse 38 market data tables and 27 figures on "Europe Animal Healthcare Market” - Forecast to 2027
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
Sales Office (U.S.) : Coherent Market Insights 1001 4th Ave,
#3200 Seattle, WA 98154, U.S.
Asia Pacific Intelligence Center (India) : Coherent Market Insights 203, 2nd Floor,
Bremen Business Center, Aundh, Pune,
Maharashtra 411007, India.
UK :
+44-020-8133-4027
JAPAN :
+81-50-5539-1737
This website is secured Origin CA certificate on the server, Comodo, Firewall and Verified Sitelock Malware Protection
US :
INDIA :
UK :
JAPAN :
Contact Us
